|
 |
| |
|
| |
Agenda subject to update before Conference Dates
For the most current version of the Conference Agenda, please refer to the Conference App. |
| Sunday, June 5 |
| 5:00 - 8:00 pm |
"Welcome to San Diego"- COCKTAIL RECEPTION |
| |
| |
| Monday, June 6 |
| 7:00 - 8:50 am |
BREAKFAST |
| 8:50 - 9:00 am |
Welcome | Day One Introductions and Announcements |
| |
2022 San Diego Co-Chairs: |
Vickie Reed, Sr. Vice President & Chief Accounting Officer, Mirati Therapeutics, Inc.
Betsy Gelfand, Vice President, Finance, Mirati Therapeutics, Inc. |
| 9:00 - 10:15 am |
KEYNOTE PRESENTATION: John Whyte, PhD, MD, Chief Medical Officer, WebMD, "The FDA and the Health Ecosystem" |
| |
Dr. John Whyte is a practicing physician and Chief Medical Officer of WebMD. As the FDA’s former Director of Professional Affairs and Stakeholder Engagement, Dr. Whyte helps audiences navigate the often-complicated regulatory process. With all the innovations in health technology, it is critical to understand the FDA’s role in the health ecosystem. Dr. Whyte will speak about insightful and entertaining topics and try to help answer the question - ‘what could the future of clinical trials look like.’ |
| 10:15 -10:30 am |
Break |
| 10:30 - 11:45 am |
KEYNOTE PRESENTATION: Ryan Lahti, PhD, Founder & Managing Principal, OrgLeader, Author, The Finesse Factor, "Succeeding Amid Uncertainty and Risk as a Financial Officer" |
|
As a financial leader, you face situations involving uncertainty and risk every day. Influencing critical decision makers, defusing conflict with colleagues, retaining top performers, and navigating office politics are examples. How you address these challenges impacts your effectiveness and the work environment you help create. As a catalyst for your success, Dr. Ryan Lahti will discuss how to flourish in uncertainty and better manage risk no matter what you encounter. |
| 11:45 - 12:55 pm |
LUNCH |
| 12:55 - 1:00 pm |
Afternoon Introductions and Announcements |
| 1:00 - 1:55 pm |
PANEL DISCUSSION: Real Estate Panel Discussion |
|
|
Panelists:
|
Dan Ryan, Co-Chief Investment Officer & Regional Market Director, Alexandria Real Estate Equities, Inc.
Ryan Egli, Executive Vice President, CBRE
Bridget Garwitz, Corporate Real Estate Advisor, Savills
Nancy Escano, Managing Principal, DGA Architects |
| 1:55 - 2:00 pm |
Break |
| 2:00 - 3:15 pm |
FIRESIDE CHAT - Legislative Update with Vince Sampson and Sonia Nath |
| |
Vince focuses on helping clients predict, navigate and understand the increasingly complex involvement of federal agencies and Congress in the regulation of the education, technology, financial services, life sciences and communications industries.
Sonia served almost 12 years in the FDA's Office of the Chief Counsel. During her tenure at FDA, Sonia gained subject matter experience across the gamut of FDA-regulated products, including pharmaceuticals, medical devices, conventional foods, dietary supplements, OTC drugs, animal drugs and biologics, and advised agency personnel on responses to industry non-compliance. |
|
|
Panelist:
Panelist:
|
Vince Sampson, Special Counsel, Cooley
Sonia Nath, Partner, Cooley
|
| 3:15 - 3:25 pm |
Break/Transition |
| 3:25 - 4:25 pm |
PANEL PRESENTATION: Analyst Panel |
| |
|
| |
|
Moderator: |
Mason Matthies, Managing Director, DFIN
Percival Barretto-Ko, President, CEO, Plexium, Inc.
Vish Setia, DIrector, Life Sciences Investment Banking, Bank of America |
| 4:25 - 4:35 pm |
Break/Transition |
| 4:35 - 5:30 pm |
COMPANY ROUNDTABLES - Select One |
| |
These company roundtables will be facilitated by Cooley LLP along with carefully selected CFOs from each of the company stages with the aim of providing a forum for thoughtful discussion of the issues relevant to each. |
| |
Early Stage Biotech Companies |
Whether public or private early stage life sciences companies face unique challenges in raising necessary capital and transacting with strategic partners and critical vendors. In this roundtable, we will explore such challenges and various tactics to prepare for and succeed in the early stage. |
| |
|
Moderator: |
Dylan Kornbluth, Associate, Cooley |
| |
Late Stage Biotech Companies |
Our panel will focus on financing opportunities and challenges, royalty deals and M&A considerations for both public and private late stage companies. |
| |
|
Moderators: |
Phillip McGill, Associate, Cooley |
| |
Commercialized Companies |
Preparing for Commercialization—The Dos and Don’ts |
| |
|
Moderators: |
Karen Elizabeth Deschaine, Partner, Cooley |
| 6:00 pm |
Evening Social Event and Networking - Baseball at Petco Park |
| |
|
|
|
| Tuesday, June 7 |
| 7:00 - 8:50 am |
BREAKFAST
ABFO Regional Coordinators' Meeting |
| 8:50 - 9:00 am |
Welcome | Day Two Introductions and Announcements |
| 9:00 - 9:55 am |
KEYNOTE SPEAKER: Jonathan Kozy, Managing Director & Senior Macro Strategy Analyst, Bank of America Merrill Lynch |
|
Jonathan's presentation will highlight key drivers of growth, critical secular trends, and the potential risks to growth and earnings in the our current economy. Key global trends affecting the US economy and capital markets will also be examined. |
| 9:55 - 10:50 am |
KEYNOTE SPEAKER: Dan Negroni, Leading Executive/Business Coach, "Chasing Relevance" |
| |
Keeping our front line managers “people” focused, engaged, interested and empowered on growth and development for themselves and the next generation employee base (worker of the future).
In today’s world over 48% of your people want to quit their job and find new work!. We are all inherently disconnected and disengaged with remote work, pandemic repercussions, and the challenges navigating guidance for talent in the workplace. Our workforce is at a loss for understanding the different perspectives and don’t know who to trust and are dying for a deeper and more meaningful connection. We need to connect and guide all of our talent because People Matter. |
| 10:50 - 10:55 am |
Break/Transition |
| 10:55 - 12:00 pm |
PANEL PRESENTATIONS, Tranche One: Select One |
| |
A. Current Insurance Trends and Debunking the D&O Craze |
The ever changing landscape of insurance, from D&O to Cyber and what are the latest trends |
| |
|
Moderators: |
Frank Paolucci, Managing Director, Northeast Region, AON Financial Services Group
Alyssa Pianelli, Esq., Vice President, AON |
| |
B. All Things Compensation |
What are the latest trends in the market as it relates to compensation? How are equity plans continuing to evolve and remain competitive? |
| |
|
Moderator: |
Karen Deschaine,
Partner, Cooley
Austin Holt, Compensation & Benefits Specialist, Cooley
|
| |
C. Automation in the Workplace |
When and how is the right approach to automation. When do you know you have outgrown your current processes? Let's deep dive into working smarter, not harder? |
| |
|
Moderators: |
Matt Andrews, RVP, LIfe Sciences, Coupa
Wanda Ionescu, CEO, R&D Logic
|
| 12:00 - 1:10 pm |
LUNCH |
| 1:10- 1:15 pm |
Afternoon Introductions and Announcements |
| 1:15 - 2:20 pm |
BREAKOUT PANEL PRESENTATIONS, Tranche Two: Select One |
| |
A. Current Insurance Trends and Debunking the D&O Craze |
The ever changing landscape of insurance, from D&O to Cyber and what are the latest trends |
| |
|
Moderators: |
Frank Paolucci, Managing Director, Northeast Region, AON Financial Services Group
Alyssa Pianelli, Esq., Vice President, AON |
| |
B. All Things Compensation |
What are the latest trends in the market as it relates to compensation?. How are equity plans continuing to evolve and remain competitive? |
| |
|
Moderator: |
Karen Deschaine,
Partner, Cooley
Austin Holt, Compensation & Benefits Specialist, Cooley
|
| |
C. Automation in the Workplace |
When and how is the right approach to automation. When do you know you have outgrown your current processes? Lets deep dive into working smarter, not harder? |
| |
|
Moderators: |
Matt Andrews, Vice President of Sales, Coupa
Wanda Ionescu, CEO, R&D Logic
|
| 2:20 - 2:35 pm |
Break/Transition |
| 2:35 - 3:35 pm |
KEYNOTE SPEAKER: Molly Bloom, The Story of the Woman Behind the Most Exclusive, High-Stakes Underground Poker Game in the World |
| |
What’s it like to run an exclusive poker game for the rich and famous? Molly Bloom went from Olympic-level skier who didn’t know a thing about poker or Hollywood to building and operating the largest and most notorious private poker game in the world. In this motivational talk, Bloom will show the sales and marketing skills she used to attract hundreds of millions of dollars to the game and spark the interest of players like Leonardo DiCaprio, Tobey Maguire, A-Rod, and Ben Affleck. Audiences will get the inside story not shown in the film as Bloom shares true-life tales of her experience. |
| 3:35 - 3:45 pm |
Break/Transition |
| 3:45 - 4:55 pm |
PANEL PRESENTATION: "Changing the Landscape of Leadership" |
| |
An interactive discussion of changing leadership during an era of continuous global, technological and social shifts. |
| |
|
Moderator:
|
Killu Sanborn, Managing Director, Oxford Finance
Katherine Vega Stultz,
President, CEO, Ocelot Bio
Eric Kaufmann, Fellow, Thought Leader, Harvard Institute of Coaching
Amy Bachrodt, Vice President, Finance, Maze Therapeutics
Maren Winnick, Senior Managing Director, Evercore |
| 5:00 - 5:15 pm |
Announcements, Closing Remarks |
| |
|
| |
30 Minute Break Before Evening Special Event |
| 5:45 pm |
San Diego Experience - Visit the historic Gaslamp district, fun local event space, walking distance to hotel. |
|
|
| Wednesday, June 8 |
| 7:00 - 8:50 am |
BREAKFAST |
| 8:50 - 9:00 am |
Welcome | Day Three Introductions and Announcements |
|
|
Introducing 2023 ABFO Conference Chair - 2023 San Francisco |
| 9:00 - 10:15 am |
ERNST & YOUNG LLP Technical Update |
| |
Update on the latest accounting developments that are expected to impact bioscience companies. EY will share their insights on how the matters are being interpreted, what bioscience companies should be focused on, and how the various regulatory bodies view these areas. |
| |
|
Moderators |
Michael Formolo, Partner, Ernst & Young LLP
Phil Howard, Partner, Ernst & Young LLP
Tom Mantione, Managing Director, Ernst & Young LLP
|
| 10:15 - 11:05 am |
ERNST & YOUNG LLP Tax Update |
| |
Update on the latest Tax developments that are expected to impact bioscience companies. EY will share their insights on how the matters are being interpreted, what bioscience companies should be focused on, and how the various regulatory bodies view these areas. |
| |
|
Moderators:
|
Chad Crocker, Managing Director, Ernst & Young LLP
Susan Chau, Senior Manager, Ernset & Young LLP |
| 11:05 - 11:10 am |
Break/Transition |
| 11:10 - 12:00 am |
SPEAKER: Perspectives from Clinical Trial Participants |
| |
In the Finance function, we don't often get the opportunity to engage with patients. This session includes a panel of patients who are willing to share their story and explain their experience as a clinical trial participant. |
| |
|
Moderator:
|
Erika Brown, Patient Advocate
Julie Johnson
Sarah Kelly
Jill McDonald
Demy O'Brien
|
| 12:00 - 12:15 pm |
Closing Remarks and Conference Concludes |
| |
|
|
|
| |
|
|
|
 |
| |
| |
